Most of the studies have found that, ANP32A function as a tumor suppressor protein [9, 14], surprisingly increased expression was found in hepatocellular carcinoma [15], colorectal cancer [16], pancreatic tumor [17] and liver cancer [15]. Here, ANP32A is linked to pancreatic neoplasm.